BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Cresset Group Launches forgeV10 and Range of Next Generation Chemistry Software


5/29/2012 9:34:23 AM

Welwyn Garden City, UK (28th May 2012) Cresset, innovative provider of software and services for molecule designers launches forgeV10 a powerful computational suite to understand SAR and design. forgeV10 gives computational chemists control and insight into activity data enabling the planning and direction of projects with confidence. ForgeV10 uses the shape and electrostatic character of molecules to create qualitative and quantitative 3D models of activity that are visually stimulating and easy to communicate.

ForgeV10 takes advantage of Cresset’s patented ligand comparison method to align, score and compare molecules from a biological view point. Cresset’s technology has been tried and tested in hundreds of projects from virtual screening to compound design. ForgeV10 is used to: decipher complex SAR and communicate the results; design better molecules based on predictions which can be trusted; prepare detailed pharmacophores; virtually screen 10,000 compounds on the desktop; and generate ADME and off-target activity profiles. The powerful capabilities afforded the user by forgeV10 are available through locally installed software or through Cresset Consultancy Services.

Meeting the needs of computational and medicinal chemists, Cresset’s new suite of next generation chemistry software comprises: forgeV10 a powerful computational suite to understand SAR and design; torchV10 an intuitive design and 3D SAR tool for medicinal chemists; torchV10lite a free 3D molecule viewing, editing and drawing tool; blazeV10 an amazing ligand based virtual screening tool; sparkV10 an exciting and powerful way of generating novel and diverse structures.

Cresset CEO, Dr Robert Scoffin said, “We are excited to bring to market these powerful tools to help companies maximize the potential of their projects. Some of the applications have simply been renamed but others have changed significantly and now include exciting new features. The release of forgeV10 as the lead off application in the Cresset pro v10 suite is a milestone in the provision of excellence in computational chemistry software.”

Scientists interested in Cresset’s next generation software can download free demos from the company’s website.

For further information on the complete range of software and services available from Cresset, please visit www.cresset-group.com, follow Cresset on Twitter (@cressetgroup) or join the LinkedIn group.

About Cresset Group Ltd

Cresset develops software for calculating and comparing the molecular Field characteristics of chemical compounds. Field technology uses the surface properties of molecules to evaluate their activities and properties, rather than relying on 2D structure similarity, which enables Cresset’s users to find more interesting, novel and relevant results than other methods. Cresset’s Fields provide a smarter, structure independent way of hit-finding, lead switching and lead optimization in drug discovery and other chemistry-based research projects. Cresset’s Field technologies have been successfully applied to a very wide range of target classes, with and without structural information, on over 100 projects for major pharmaceutical and biotechnology companies. www.cresset-group.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES